메뉴 건너뛰기




Volumn 12, Issue 1, 2012, Pages 35-42

Perspectives in the diagnosis and prediction of preeclampsia

Author keywords

biochemical markers; early diagnosis; preeclampsia; promising markers

Indexed keywords


EID: 85087172175     PISSN: 17266122     EISSN: 23095148     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (6)

References (67)
  • 1
    • 67349083892 scopus 로고    scopus 로고
    • Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis
    • Adya R., Tan B.K., Chen J., Randeva H.S. Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis 2009; 205: 113—119.
    • (2009) Atherosclerosis , vol.205 , pp. 113-119
    • Adya, R.1    Tan, B.K.2    Chen, J.3    Randeva, H.S.4
  • 2
    • 31544441013 scopus 로고    scopus 로고
    • Low urinary placental growth factor is a marker of pre-eclampsia
    • Aggarwal P.K., Jain V., Sakhuja V. et al. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int 2006; 69: 621—624.
    • (2006) Kidney Int , vol.69 , pp. 621-624
    • Aggarwal, P.K.1    Jain, V.2    Sakhuja, V.3
  • 3
    • 0036019539 scopus 로고    scopus 로고
    • Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia
    • Aksoy H., Kumtepe Y., Akcay F., Yildirim A.K. Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia. Clin Exp Med 2002; 2: 39—43.
    • (2002) Clin Exp Med , vol.2 , pp. 39-43
    • Aksoy, H.1    Kumtepe, Y.2    Akcay, F.3    Yildirim, A.K.4
  • 4
    • 36148972797 scopus 로고    scopus 로고
    • Performance of a panel of maternal serum markers in predicting preeclampsia at 11—15 weeks’ gestation
    • Banzola I., Farina A., Concu M. et al. Performance of a panel of maternal serum markers in predicting preeclampsia at 11—15 weeks’ gestation. Prenat Diagn 2007; 27: 1005—1010.
    • (2007) Prenat Diagn , vol.27 , pp. 1005-1010
    • Banzola, I.1    Farina, A.2    Concu, M.3
  • 5
    • 0037342076 scopus 로고    scopus 로고
    • Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction
    • Bretelle F., Sabatier F., Desprez D. et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 2003; 89: 486—492.
    • (2003) Thromb Haemost , vol.89 , pp. 486-492
    • Bretelle, F.1    Sabatier, F.2    Desprez, D.3
  • 6
    • 3242708015 scopus 로고    scopus 로고
    • Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies
    • Burger O., Pick E., Zwickel J. et al. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004; 25: 608—622.
    • (2004) Placenta , vol.25 , pp. 608-622
    • Burger, O.1    Pick, E.2    Zwickel, J.3
  • 7
    • 33646076702 scopus 로고    scopus 로고
    • Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction
    • Cetin I., Cozzi V., Pasqualini F. et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynec 2006; 194: 1347—1353.
    • (2006) Am J Obstet Gynec , vol.194 , pp. 1347-1353
    • Cetin, I.1    Cozzi, V.2    Pasqualini, F.3
  • 8
    • 3442884269 scopus 로고    scopus 로고
    • Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award
    • Chaiworapongsa T., Romero R., Espinoza J. et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynec 2004; 190: 1541—1547.
    • (2004) Am J Obstet Gynec , vol.190 , pp. 1541-1547
    • Chaiworapongsa, T.1    Romero, R.2    Espinoza, J.3
  • 9
    • 20244362656 scopus 로고    scopus 로고
    • Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
    • Chaiworapongsa T., Romero R., Kim Y.M. et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 3—18.
    • (2005) J Matern Fetal Neonatal Med , vol.17 , pp. 3-18
    • Chaiworapongsa, T.1    Romero, R.2    Kim, Y.M.3
  • 10
    • 37849018744 scopus 로고    scopus 로고
    • Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age
    • Chaiworapongsa T., Romero R., Gotsch F. et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med 2008; 21: 41—52.
    • (2008) J Matern Fetal Neonatal Med , vol.21 , pp. 41-52
    • Chaiworapongsa, T.1    Romero, R.2    Gotsch, F.3
  • 11
    • 0035988790 scopus 로고    scopus 로고
    • Soluble adhesion molecule profile in normal pregnancy and preeclampsia
    • Chaiworapongsa T., Romero R., Yoshimatsu J. et al. Soluble adhesion molecule profile in normal pregnancy and preeclampsia. J Matern Fetal Neonatal Med 2002; 12: 19—27.
    • (2002) J Matern Fetal Neonatal Med , vol.12 , pp. 19-27
    • Chaiworapongsa, T.1    Romero, R.2    Yoshimatsu, J.3
  • 12
    • 41049110633 scopus 로고    scopus 로고
    • Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia
    • Chavarria M.E., Lara-Gonzalez L., Garcia-Paleta Y. et al. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol 2008; 137: 157—164.
    • (2008) Eur J Obstet Gynecol Reprod Biol , vol.137 , pp. 157-164
    • Chavarria, M.E.1    Lara-Gonzalez, L.2    Garcia-Paleta, Y.3
  • 13
    • 33947394077 scopus 로고    scopus 로고
    • First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system
    • Cowans N.J., Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007; 27: 264—271.
    • (2007) Prenat Diagn , vol.27 , pp. 264-271
    • Cowans, N.J.1    Spencer, K.2
  • 14
    • 33845956065 scopus 로고    scopus 로고
    • Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia
    • Diesch C.H., Holzgreve W., Hahn S., Zhong X.Y. Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenat Diagn 2006; 26: 1267—1270.
    • (2006) Prenat Diagn , vol.26 , pp. 1267-1270
    • Diesch, C.H.1    Holzgreve, W.2    Hahn, S.3    Zhong, X.Y.4
  • 15
    • 13444267698 scopus 로고    scopus 로고
    • Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection
    • Dragun D., Muller D.N., Brasen J.H. et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558—569.
    • (2005) N Engl J Med , vol.352 , pp. 558-569
    • Dragun, D.1    Muller, D.N.2    Brasen, J.H.3
  • 16
    • 7044251939 scopus 로고    scopus 로고
    • First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)
    • Dugoff L., Hobbins J.C., Malone F.D. et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial) Am J Obstet Gynec 2004; 191: 1446—1451.
    • (2004) Am J Obstet Gynec , vol.191 , pp. 1446-1451
    • Dugoff, L.1    Hobbins, J.C.2    Malone, F.D.3
  • 17
    • 43249093630 scopus 로고    scopus 로고
    • The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-forgestational age
    • Erez O., Romero R., Espinoza J. et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-forgestational age. J Matern Fetal Neonatal Med 2008; 21: 279—287.
    • (2008) J Matern Fetal Neonatal Med , vol.21 , pp. 279-287
    • Erez, O.1    Romero, R.2    Espinoza, J.3
  • 18
    • 33846900883 scopus 로고    scopus 로고
    • Defferential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function
    • Fasshauer M., Bluher M., Stumvoll M. et al. Defferential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf) 2007; 66: 434—439.
    • (2007) Clin Endocrinol (Oxf) , vol.66 , pp. 434-439
    • Fasshauer, M.1    Bluher, M.2    Stumvoll, M.3
  • 19
    • 19944433652 scopus 로고    scopus 로고
    • Visfatin: a protein secreted by visceral fat that mimics the effects of insulin
    • Fukuhara A., Matsuda M., Nishizawa M. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426—430.
    • (2005) Science , vol.307 , pp. 426-430
    • Fukuhara, A.1    Matsuda, M.2    Nishizawa, M.3
  • 20
    • 0347993133 scopus 로고    scopus 로고
    • Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies
    • Gratton R.J., Gluszynski M., Mazzuca D.M. et al. Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2003; 88: 6048—6055.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 6048-6055
    • Gratton, R.J.1    Gluszynski, M.2    Mazzuca, D.M.3
  • 21
    • 43449134064 scopus 로고    scopus 로고
    • AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia
    • Herse F., Staff A.C., Hering L. et al. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med 2008; 86: 697—703.
    • (2008) J Mol Med , vol.86 , pp. 697-703
    • Herse, F.1    Staff, A.C.2    Hering, L.3
  • 22
    • 59849123575 scopus 로고    scopus 로고
    • Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study
    • Herse F., Verlohren S., Wenzel K. et al. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009; 53: 393—398.
    • (2009) Hypertension , vol.53 , pp. 393-398
    • Herse, F.1    Verlohren, S.2    Wenzel, K.3
  • 23
    • 2342417817 scopus 로고    scopus 로고
    • Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women
    • Holthe M.R., Staff A.C., Berge L.N., Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynec 2004; 190: 1128—1134.
    • (2004) Am J Obstet Gynec , vol.190 , pp. 1128-1134
    • Holthe, M.R.1    Staff, A.C.2    Berge, L.N.3    Lyberg, T.4
  • 24
    • 41649118423 scopus 로고    scopus 로고
    • Serum visfatin levels in late pregnancy and pre-eclampsia
    • Hu W., Wang Z., Wang H. et al. Serum visfatin levels in late pregnancy and pre-eclampsia. Acta Obstet Gynec Scand 2008; 87: 413—418.
    • (2008) Acta Obstet Gynec Scand , vol.87 , pp. 413-418
    • Hu, W.1    Wang, Z.2    Wang, H.3
  • 25
    • 50049108374 scopus 로고    scopus 로고
    • Longitudinal determination of serum placental protein 13 during development of preeclampsia
    • Huppertz B., Sammar M., Chefetz I. et al. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 2008; 24: 230—236.
    • (2008) Fetal Diagn Ther , vol.24 , pp. 230-236
    • Huppertz, B.1    Sammar, M.2    Chefetz, I.3
  • 26
    • 43849113456 scopus 로고    scopus 로고
    • Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia
    • Jeyabalan A., McGonigal S., Gilmour C. et al. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta 2008; 29: 555—563.
    • (2008) Placenta , vol.29 , pp. 555-563
    • Jeyabalan, A.1    McGonigal, S.2    Gilmour, C.3
  • 27
    • 67749147528 scopus 로고    scopus 로고
    • First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk
    • Khalil A., Cowans N.J., Spencer K. et al. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn 2009; 8: 781—789.
    • (2009) Prenat Diagn , vol.8 , pp. 781-789
    • Khalil, A.1    Cowans, N.J.2    Spencer, K.3
  • 28
    • 0027197671 scopus 로고
    • Adrenomedulli: a novel hypotensive peptide isolated from human pheochromocytoma
    • Kitamura K., Kangawa K., Kawamoto M. et al. Adrenomedulli: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553—560.
    • (1993) Biochem Biophys Res Commun , vol.192 , pp. 553-560
    • Kitamura, K.1    Kangawa, K.2    Kawamoto, M.3
  • 29
    • 7044261025 scopus 로고    scopus 로고
    • Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes
    • Krantz D., Goetzl L., Simpson J.L. et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynec 2004; 191: 1452—1458.
    • (2004) Am J Obstet Gynec , vol.191 , pp. 1452-1458
    • Krantz, D.1    Goetzl, L.2    Simpson, J.L.3
  • 30
    • 21244479342 scopus 로고    scopus 로고
    • Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia
    • Laigaard J., Sorensen T., Placing S. et al. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynec 2005; 106: 144—149.
    • (2005) Obstet Gynec , vol.106 , pp. 144-149
    • Laigaard, J.1    Sorensen, T.2    Placing, S.3
  • 31
    • 18044370643 scopus 로고    scopus 로고
    • Circulating angiogenic factors in preeclampsia
    • Levine R.J., Karumanchi S.A. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynec 2005; 48: 372—386.
    • (2005) Clin Obstet Gynec , vol.48 , pp. 372-386
    • Levine, R.J.1    Karumanchi, S.A.2
  • 32
    • 10744227199 scopus 로고    scopus 로고
    • Circulating angiogenic factors and the risk of preeclampsia
    • Levine R.J., Maynard S.E., Qian C. et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672—683.
    • (2004) N Engl J Med , vol.350 , pp. 672-683
    • Levine, R.J.1    Maynard, S.E.2    Qian, C.3
  • 33
    • 1642423713 scopus 로고    scopus 로고
    • Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia
    • Levine R.J., Qian C., LeShane E.S. et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynec 2004; 190: 707—713.
    • (2004) Am J Obstet Gynec , vol.190 , pp. 707-713
    • Levine, R.J.1    Qian, C.2    LeShane, E.S.3
  • 34
    • 19944426139 scopus 로고    scopus 로고
    • Urinary placental growth factor and risk of preeclampsia
    • Levine R.J., Thadhani R., Qian C. et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005; 293: 77—85.
    • (2005) JAMA , vol.293 , pp. 77-85
    • Levine, R.J.1    Thadhani, R.2    Qian, C.3
  • 35
    • 0342618532 scopus 로고    scopus 로고
    • Presence of fetal DNA in maternal plasma and serum
    • Lo Y.M., Corbetta N., Chamberlain P.F. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485—487.
    • (1997) Lancet , vol.350 , pp. 485-487
    • Lo, Y.M.1    Corbetta, N.2    Chamberlain, P.F.3
  • 36
    • 33847013371 scopus 로고    scopus 로고
    • Microparticle-associated P-selectin reflects platelet activation in preeclampsia
    • Lok C.A., Nieuwland R., Sturk A. et al. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets 2007; 18: 68—72.
    • (2007) Platelets , vol.18 , pp. 68-72
    • Lok, C.A.1    Nieuwland, R.2    Sturk, A.3
  • 37
    • 0037373006 scopus 로고    scopus 로고
    • Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
    • Maynard S.E., Min J.Y., Merchan J. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649—658.
    • (2003) J Clin Invest , vol.111 , pp. 649-658
    • Maynard, S.E.1    Min, J.Y.2    Merchan, J.3
  • 38
    • 34548446787 scopus 로고    scopus 로고
    • Angiogenic factors for the prediction of preeclampsia in high-risk women
    • Moore Simas T.A., Crawford S.L. et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynec 2007; 197: 244—248.
    • (2007) Am J Obstet Gynec , vol.197 , pp. 244-248
    • Moore Simas, T.A.1    Crawford, S.L.2
  • 39
    • 33846527541 scopus 로고    scopus 로고
    • Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
    • Moschen A.R., Kaser A., Enrich B. et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunology 2007; 178: 1748—1758.
    • (2007) J Immunology , vol.178 , pp. 1748-1758
    • Moschen, A.R.1    Kaser, A.2    Enrich, B.3
  • 40
    • 31144463307 scopus 로고    scopus 로고
    • A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound
    • Nicolaides K.H., Bindra R., Turan O.M. et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynec 2006; 27: 13—17.
    • (2006) Ultrasound Obstet Gynec , vol.27 , pp. 13-17
    • Nicolaides, K.H.1    Bindra, R.2    Turan, O.M.3
  • 41
    • 58149292244 scopus 로고    scopus 로고
    • First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome
    • Poon L.C., Chelemen T., Granvillano O. et al. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynec 2008; 112: 1082— 1090.
    • (2008) Obstet Gynec , vol.112 , pp. 1082-1090
    • Poon, L.C.1    Chelemen, T.2    Granvillano, O.3
  • 42
    • 34250858133 scopus 로고    scopus 로고
    • Sequential changes in antiangiogenic factors in early pregnancy and risk of developing pr eeclampsia
    • Rana S., Karumanchi S.A., Levine R.J. et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing pr eeclampsia. Hypertension 2007; 50: 137—142.
    • (2007) Hypertension , vol.50 , pp. 137-142
    • Rana, S.1    Karumanchi, S.A.2    Levine, R.J.3
  • 43
    • 60249089098 scopus 로고    scopus 로고
    • The two stage model of preeclampsia: variations on the theme
    • Roberts J.M., Hubel C.A. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30: 32—37.
    • (2009) Placenta , vol.30 , pp. 32-37
    • Roberts, J.M.1    Hubel, C.A.2
  • 44
    • 33745274791 scopus 로고    scopus 로고
    • Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia
    • Robinson C.J., Johnson D.D., Chang E.Y. et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynec 2006; 195: 255—259.
    • (2006) Am J Obstet Gynec , vol.195 , pp. 255-259
    • Robinson, C.J.1    Johnson, D.D.2    Chang, E.Y.3
  • 45
    • 34547578314 scopus 로고    scopus 로고
    • Soluble endoglin as a second-trimester marker for preeclampsia
    • Robinson C.J., Johnson D.D. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynec 2007; 197: 174— 175.
    • (2007) Am J Obstet Gynec , vol.197 , pp. 174-175
    • Robinson, C.J.1    Johnson, D.D.2
  • 46
    • 48149087254 scopus 로고    scopus 로고
    • First-trimester maternal serum PP13 in the risk assessment for preeclampsia
    • Romero R., Kusanovic J.P., Than N.G. et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynec 2008; 199: 122.
    • (2008) Am J Obstet Gynec , vol.199 , pp. 122
    • Romero, R.1    Kusanovic, J.P.2    Than, N.G.3
  • 47
    • 37849021866 scopus 로고    scopus 로고
    • A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
    • Romero R., Nien J.K., Espinoza J. et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9—23.
    • (2008) J Matern Fetal Neonatal Med , vol.21 , pp. 9-23
    • Romero, R.1    Nien, J.K.2    Espinoza, J.3
  • 48
    • 33746890890 scopus 로고    scopus 로고
    • Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia
    • Rovere-Querini P., Antonacci S., Dell’Antonio G. et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynec 2006; 108: 148—155.
    • (2006) Obstet Gynec , vol.108 , pp. 148-155
    • Rovere-Querini, P.1    Antonacci, S.2    Dell’Antonio, G.3
  • 49
    • 34347249118 scopus 로고    scopus 로고
    • Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
    • Salahuddin S., Lee Y., Vadnais M. et al. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynec 2007; 197: 28—36.
    • (2007) Am J Obstet Gynec , vol.197 , pp. 28-36
    • Salahuddin, S.1    Lee, Y.2    Vadnais, M.3
  • 50
    • 41549112891 scopus 로고    scopus 로고
    • Study of plasma adrenomedullin level in normal pregnancy and preclampsia
    • Senna A.A., Zedan M., Salam G.E., Mashad A.I. Study of plasma adrenomedullin level in normal pregnancy and preclampsia. Medscape J Med 2008; 10: 29.
    • (2008) Medscape J Med , vol.10 , pp. 29
    • Senna, A.A.1    Zedan, M.2    Salam, G.E.3    Mashad, A.I.4
  • 51
    • 67650327064 scopus 로고    scopus 로고
    • Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
    • Sheng Wen Liu, Shu Bin Qiao, Jian Song Yuan, Dong Qin Liu. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol 2009; 71: 2: 202—207.
    • (2009) Clin Endocrinol , vol.71 , Issue.2 , pp. 202-207
    • Liu, Sheng Wen1    Qiao, Shu Bin2    Yuan, Jian Song3    Liu, Dong Qin4
  • 53
    • 41149086146 scopus 로고    scopus 로고
    • ADAM12s in maternal serum as a potential marker of pre-eclampsia
    • Spencer K., Cowans N.J., Stamatopoulou A. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Prenat Diagn 2008; 28: 212—216.
    • (2008) Prenat Diagn , vol.28 , pp. 212-216
    • Spencer, K.1    Cowans, N.J.2    Stamatopoulou, A.3
  • 54
    • 33847277304 scopus 로고    scopus 로고
    • First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia
    • Spencer K., Cowans N.J., Chefetz I. et al. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia. Ultrasound Obstet Gynec 2007; 29: 128—134.
    • (2007) Ultrasound Obstet Gynec , vol.29 , pp. 128-134
    • Spencer, K.1    Cowans, N.J.2    Chefetz, I.3
  • 55
    • 33947388873 scopus 로고    scopus 로고
    • Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of preeclampsia
    • Spencer K., Cowans N.J., Chefetz I. et al. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of preeclampsia. Prenat Diagn 2007; 27: 258—263.
    • (2007) Prenat Diagn , vol.27 , pp. 258-263
    • Spencer, K.1    Cowans, N.J.2    Chefetz, I.3
  • 56
    • 39149131084 scopus 로고    scopus 로고
    • Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia
    • Spencer K., Cowans N.J., Nicolaides K.H. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008; 28: 7—10.
    • (2008) Prenat Diagn , vol.28 , pp. 7-10
    • Spencer, K.1    Cowans, N.J.2    Nicolaides, K.H.3
  • 57
    • 43249123064 scopus 로고    scopus 로고
    • First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery
    • Spencer K., Cowans N.J., Molina F. et al. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynec 2008; 31: 147—152.
    • (2008) Ultrasound Obstet Gynec , vol.31 , pp. 147-152
    • Spencer, K.1    Cowans, N.J.2    Molina, F.3
  • 58
    • 34447125104 scopus 로고    scopus 로고
    • Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction
    • Stepan H., Kramer T., Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2007; 92: 2831—2834.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 2831-2834
    • Stepan, H.1    Kramer, T.2    Faber, R.3
  • 59
    • 34047232484 scopus 로고    scopus 로고
    • Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion
    • Stepan H., Unversucht A., Wessel N., Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007; 49: 818—824.
    • (2007) Hypertension , vol.49 , pp. 818-824
    • Stepan, H.1    Unversucht, A.2    Wessel, N.3    Faber, R.4
  • 60
    • 38349087878 scopus 로고    scopus 로고
    • Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion
    • Stepan H., Geipel A., Schwarz F. et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynec 2008; 198: 175—176.
    • (2008) Am J Obstet Gynec , vol.198 , pp. 175-176
    • Stepan, H.1    Geipel, A.2    Schwarz, F.3
  • 61
    • 1442303327 scopus 로고    scopus 로고
    • First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia
    • Thadhani R., Mutter W.P., Wolf M. et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770—775.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 770-775
    • Thadhani, R.1    Mutter, W.P.2    Wolf, M.3
  • 62
    • 10744232684 scopus 로고    scopus 로고
    • Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences
    • Tsatsaris V., Goffin F., Munaut C. et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003; 88: 5555—5563.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 5555-5563
    • Tsatsaris, V.1    Goffin, F.2    Munaut, C.3
  • 63
    • 33744985816 scopus 로고    scopus 로고
    • Soluble endoglin contributes to the pathogenesis of preeclampsia
    • Venkatesha S., Toporsian M., Lam C. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642—649.
    • (2006) Nat Med , vol.12 , pp. 642-649
    • Venkatesha, S.1    Toporsian, M.2    Lam, C.3
  • 64
    • 31944451457 scopus 로고    scopus 로고
    • Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature
    • Walther T., Wallukat G., Jank A. et al. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 2005; 46: 1275—1279.
    • (2005) Hypertension , vol.46 , pp. 1275-1279
    • Walther, T.1    Wallukat, G.2    Jank, A.3
  • 65
    • 30344453927 scopus 로고    scopus 로고
    • Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation
    • Wathen K.A., Tuutti E., Stenman U.H. et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 2006; 91: 180—184.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 180-184
    • Wathen, K.A.1    Tuutti, E.2    Stenman, U.H.3
  • 66
    • 34249908643 scopus 로고    scopus 로고
    • Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia
    • Wikstrom A.K., Larsson A., Eriksson U.J. et al. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynec 2007; 109: 1368—1374.
    • (2007) Obstet Gynec , vol.109 , pp. 1368-1374
    • Wikstrom, A.K.1    Larsson, A.2    Eriksson, U.J.3
  • 67
    • 40849105128 scopus 로고    scopus 로고
    • Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling
    • Zhou C.C., Ahmad S., Mi T. et al. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008; 51: 1010—1019.
    • (2008) Hypertension , vol.51 , pp. 1010-1019
    • Zhou, C.C.1    Ahmad, S.2    Mi, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.